Skip to Content

Takeda Pharmaceutical to Launch Sales Unit in Brazil in Feb.

Takeda Pharmaceutical to Launch Sales Unit in Brazil in Feb. [Kyodo News International, Tokyo]

From Kyodo News International (Tokyo, Japan) (December 2, 2009)

Dec. 2--TOKYO -- Takeda Pharmaceutical Co. said Wednesday it will set up a sales subsidiary in Brazil in February 2010 to boost the major Japanese drug maker’s presence in the potential growth market of Latin America.

Takeda said it will launch its wholly owned sales subsidiary in Sao Paulo, Brazil, whose pharmaceutical market accounts for over 40 percent of pharmaceutical sales in Latin America and is predicted to expand by 8.5 percent every year until 2013.

Takeda said its Brazil unit will import and market Takeda products for Brazil, marking the 12th country it has entered as part of its global strategic expansion from January 2009. Takeda’s products include Kapidex gastrointestinal drugs.

In addition to breaking into the market of emerging economies, the drug maker is also stepping up efforts to expand its operations in Europe. Takeda has so far launched sales units in several countries in Europe including Spain, Denmark and Sweden.

"Combined with Takeda’s additional recent expansions, this opportunity will drive Takeda’s ability to maximize the potential of our pipeline in Brazil," said Alan MacKenzie, executive vice president for international operations at Takeda Pharmaceuticals International Inc., a wholly owned unit of Takeda America Holdings Inc. in New York.

To see more of Kyodo News International, go to

Copyright (c) 2009, Kyodo News International, Tokyo

Distributed by McClatchy-Tribune Information Services.

For reprints, email, call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

Posted: December 2009